Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
450 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04585490 | Adaptive ctDNA-Based Personalization of Treatment During Consolidation Therapy in NSCLC | recruiting | Phase 3 | 48 | Stanford UniversityOTHER | 1 | Sep 30, 2026 | clinicaltrials |
| NCT06855628 | Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM) | completed | Phase 2 | 2 | Stanford UniversityOTHER | 1 | Sep 30, 2026 | clinicaltrials |
| NCT07634536 |
| Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant |
| not yet recruiting |
| Phase 2 |
| 30 |
| Stanford UniversityOTHER |
| 1 |
| Sep 30, 2026 |
| clinicaltrials |
| NCT04085887 | Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures | recruiting | Phase 1 / Phase 2 | 12 | Stanford UniversityOTHER | 1 | Sep 29, 2026 | clinicaltrials |
| NCT05474378 | B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme | recruiting | Phase 1 | 39 | Stanford UniversityOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT05880797 | Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma | recruiting | — | 1,000 | Stanford UniversityOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT07087002 | GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults | recruiting | Phase 1 | 18 | Stanford UniversityOTHER | 1 | Sep 11, 2026 | clinicaltrials |
| NCT07767448 | Skin Changes From the Use of Moisturizers in Participants With Cancer Experiencing Dermatological Adverse Events | not yet recruiting | N/A | 50 | Stanford UniversityOTHER | 1 | Sep 11, 2026 | clinicaltrials |
| NCT06646627 | Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors | recruiting | Phase 1 | 48 | Stanford UniversityOTHER | 1 | Sep 10, 2026 | clinicaltrials |
| NCT07594431 | Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases. | recruiting | Phase 2 | 80 | Stanford UniversityOTHER | 1 | Sep 9, 2026 | clinicaltrials |
| NCT07403981 | Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients | recruiting | N/A | 60 | Stanford UniversityOTHER | 1 | Sep 8, 2026 | clinicaltrials |
| NCT07522177 | Animated Storytelling to Promote Colorectal Cancer Screening | not yet recruiting | N/A | 3,000 | Stanford UniversityOTHER | 1 | Sep 4, 2026 | clinicaltrials |
| NCT07802834 | Adjuvant ctDNA-Adapted Treatment With Zipalertinib in Early-Stage Atypical EGFR-Mutant NSCLC | not yet recruiting | Phase 2 | 42 | Stanford UniversityOTHER | 0 | Sep 3, 2026 | clinicaltrials |
| NCT03801434 | Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders | active not recruiting | Phase 2 | 8 | Stanford UniversityOTHER | 1 | Sep 1, 2026 | clinicaltrials |
| NCT06408194 | Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies | recruiting | Phase 1 | 28 | Stanford UniversityOTHER | 1 | Sep 1, 2026 | clinicaltrials |
| NCT07791446 | End Hole vs. Pressure-Modulated Delivery of Y-90 Resin Microspheres to Liver Metastases. | not yet recruiting | N/A | 65 | Stanford UniversityOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07443137 | CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study) | not yet recruiting | Phase 1 | 20 | Stanford UniversityOTHER | 0 | Aug 27, 2026 | clinicaltrials |
| NCT06705218 | Exploring Mindsets, Beliefs and Resilience Across the Cancer Experience(EMBRACE) | active not recruiting | N/A | 440 | Stanford UniversityOTHER | 1 | Aug 26, 2026 | clinicaltrials |
| NCT07606443 | COMUNICAR: Community-Led Family-Centered Communication for Cancer Survivorship Care | not yet recruiting | N/A | 18 | Stanford UniversityOTHER | 1 | Aug 21, 2026 | clinicaltrials |
| NCT07615270 | A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement | not yet recruiting | Early Phase 1 | 5 | Stanford UniversityOTHER | 1 | Aug 21, 2026 | clinicaltrials |
| NCT07302776 | TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT | recruiting | Phase 1 | 50 | Stanford UniversityOTHER | 1 | Aug 17, 2026 | clinicaltrials |
| NCT04017819 | Biodistribution & Pharmacokinetic of Position Emission Tomography (PET) Radiopharmaceutical 18F C SNAT4 | suspended | Phase 1 | 20 | Stanford UniversityOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT04609592 | Study of PRRT in Metastatic, WHO Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery | active not recruiting | Phase 1 | 10 | Stanford UniversityOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT04768426 | Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer | recruiting | Phase 2 | 40 | Stanford UniversityOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT05188170 | Niclosamide in Pediatric Patients With Relapsed and Refractory AML | recruiting | Phase 1 | 16 | Stanford UniversityOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT05302583 | Aromatherapy Inhaler Use for HSCT Distress | recruiting | N/A | 50 | Stanford UniversityOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT05366699 | LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy | recruiting | N/A | 100 | Stanford UniversityOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT06340737 | AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas | recruiting | Phase 1 | 148 | Stanford UniversityOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT06824441 | Feasibility Usability & Acceptability Study: Symptom Reporting by Children Adolescents & Young Adults w/Cancer | active not recruiting | N/A | 85 | Stanford UniversityOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT05201534 | Interventions in Mathematics and Cognitive Skills | recruiting | N/A | 180 | Stanford UniversityOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT04392622 | d-Limonene +Radiation +PlatinumBasedChemo for Xerostomia Prevention in LocallyAdvanced HNSCC | recruiting | Phase 1 | 40 | Stanford UniversityOTHER | 1 | Jul 28, 2026 | clinicaltrials |
| NCT04662554 | Study of a 1-Millimeter Resolution Clinical Positron Emission Tomography (PET) System in Head and Neck Cancer Imaging | not yet recruiting | N/A | 10 | Stanford UniversityOTHER | 1 | Jul 27, 2026 | clinicaltrials |
| NCT05415007 | GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer | recruiting | N/A | 40 | Stanford UniversityOTHER | 1 | Jul 27, 2026 | clinicaltrials |
| NCT06173401 | Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases | recruiting | Phase 3 | 274 | Stanford UniversityOTHER | 1 | Jul 27, 2026 | clinicaltrials |
| NCT07577999 | The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy | not yet recruiting | Early Phase 1 | 20 | Stanford UniversityOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT06461988 | Talquetamab & Lenalidomide as Post Stem Cell Transplant Maintenance in Multiple Myeloma | recruiting | Phase 2 | 20 | Stanford UniversityOTHER | 1 | Jul 17, 2026 | clinicaltrials |
| NCT04585477 | Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E) | suspended | Phase 2 | 80 | Stanford UniversityOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT02346253 | High-Dose Brachytherapy in Treating Patients With Prostate Cancer | completed | N/A | 146 | Stanford UniversityOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT00568490 | Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers | recruiting | — | 200 | Stanford UniversityOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT01035112 | Magnetic Resonance Imaging of Breast Cancer | recruiting | N/A | 500 | Stanford UniversityOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT04256018 | Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome | recruiting | Phase 2 | 30 | Stanford UniversityOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT03241940 | Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell Malignancies | active not recruiting | Phase 1 | 33 | Stanford UniversityOTHER | 1 | Jun 30, 2026 | clinicaltrials |
| NCT03510208 | Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery | recruiting | Phase 1 / Phase 2 | 46 | Stanford UniversityOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT05283564 | Study to Evaluate Percussive Ventilation Breathhold to Improve Lung Stereotactic Ablative Radiotherapy | completed | N/A | 25 | Stanford UniversityOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT04925544 | Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies | active not recruiting | Phase 2 | 13 | Stanford UniversityOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT05416554 | Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford | withdrawn | N/A | 0 | Stanford UniversityOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT06551584 | Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT | recruiting | Phase 1 | 24 | Stanford UniversityOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT06592599 | Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC) | recruiting | Phase 2 | 24 | Stanford UniversityOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT07022470 | Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT). | recruiting | Phase 2 | 41 | Stanford UniversityOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT06087861 | 5-Day Preoperative Radiation for Soft Tissue Sarcoma | recruiting | Phase 2 | 75 | Stanford UniversityOTHER | 1 | Jun 10, 2026 | clinicaltrials |
Data updated 8 hours agoSource updated unknownsource: clinicaltrials